Healthtech Startups

KIYATEC develops 3D Predict, a tumor-specific testing platform that uses patient-derived tumor cells to predict how individual cancers respond to therapies. It serves oncologists and cancer patients in the precision oncology and diagnostics space.

2 investors

KLOwen Orthodontics builds a full custom digital orthodontic system, including a custom bracket portfolio, cloud-based treatment planning software, a digital lab, and 3D-printed indirect bonding trays. It serves licensed orthodontists, aiming to reduce treatment time and the number of patient appointments.

2 investors

Knipper provides multi-modal pharmaceutical fulfillment and dispensing services, including patient access solutions, pharmacy fulfillment, samples management, and third-party logistics for pharma companies. Its offerings, marketed under CareTria, aim to speed the path from prescription order to patient therapy and support prescriber engagement.

2 investors

Knopp Biosciences is a privately held company that manages a portfolio of future milestone payments and product royalties from drug pipelines it sold or spun off in 2022. Its Kv7 small-molecule platform for epilepsy and hyperexcitability disorders was acquired by Biohaven Pharmaceuticals, and its dexpramipexole platform was spun off to Areteia Therapeutics.

2 investors

Knowtex provides enterprise clinical AI infrastructure that automates documentation, coding, and administrative workflows across healthcare systems by processing clinical dialogue and unifying fragmented EHR data. The platform reduces clinician administrative burden while maintaining HIPAA compliance and governance visibility for health systems at scale.

2 investors

Koala is an online pharmacy that sells vet-approved medications, supplements, and health products for pets, with free shipping on orders over $45. The company serves pet owners seeking convenient access to prescription and over-the-counter veterinary medications and health products.

2 investors

Kodda provides structured health and lifestyle programs designed and guided by professionals to help users achieve sustainable personal wellness improvements.

2 investors

Koite Health develops patented dual-light technology for dental care and oral health treatments, offering products like Lumoral for both preventive and therapeutic use alongside a subscription tablet line. The company serves dental professionals and consumers in a €20 billion addressable market segment, with expansion potential into mucositis treatment.

2 investors

Kometa Bio develops dental surgical devices, specifically the Smart Dentin Grinder, which processes autologous dentin for bone augmentation procedures in dental practice.

2 investors

Korsana develops technology to deliver large-molecule biologic drugs across the blood-brain barrier using transferrin receptor shuttling, aimed at treating neurodegenerative diseases such as Alzheimer's. Its approach uses antibody engineering to enable therapies with meaningful central nervous system exposure delivered subcutaneously.

2 investors

Kouper builds an AI platform that automates patient-facing healthcare workflows — including appointment scheduling, insurance verification, discharge planning, and care coordination — for healthcare organizations. It aims to improve patient engagement and reduce operational burden for care teams in high-volume clinical environments.

2 investors

Kovina develops first-in-class small molecule antiviral drugs to treat HPV-induced cancers and premalignant infections such as cervical and anal dysplasia. The company aims to offer non-surgical treatment options for patients living with HPV.

2 investors

Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.

2 investors

KYMIRA develops advanced smart textile technologies embedded directly into clothing for continuous health monitoring and performance support. The company serves elite sport, healthcare, defense, and consumer markets with clinically validated infrared, filtration, and biomedical sensing technologies.

2 investors

Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.

2 investors

kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns. The company operates in the biotech sector and is based in Paris within the Paris Biotech Santé incubator.

2 investors

L-Nutra develops fasting-mimicking technology and nutrition-based products designed to slow biological aging and treat age-related diseases. The company focuses on translating longevity research into consumer health interventions.

2 investors

LabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

2 investors

Lace Health helps integrative and functional medicine clinicians start and run their own practices, handling business planning, financial modeling, credentialing and payer contracting, billing/RCM, EHR and AI tooling, and marketing. It serves physicians, nurse practitioners, and physician assistants across the US who want to launch values-aligned private practices.

2 investors

LainaHealth provides virtual physical therapy care delivered by licensed therapists paired with an AI voice assistant, designed to make musculoskeletal and recovery care universally accessible and affordable. The platform serves patients seeking rehabilitation and wellness, operating as a digital healthcare provider in the physical therapy and remote care sector.

2 investors

Lakeshore Biopharma (Nasdaq: LSB, formerly Yisheng Biopharma) is a biopharmaceutical company focused on developing, producing, and selling vaccines and immunological products for infectious diseases. Its main marketed product is a lyophilized human rabies vaccine (Vero cell), and it uses a proprietary PIKA immunomodulating technology.

2 investors

Laminate Medical Technologies develops solutions for arteriovenous fistulas in hemodialysis patients, with a focus on reducing primary fistula failure rates. The company produces VasQ, an external support device designed to improve fistula functionality without requiring additional procedures.

2 investors

Optum Care at Home provides in-home medical care and care navigation services for people enrolled in eligible health plans, including yearly in-home health visits, health screenings, and coordination of benefits like transportation and food assistance. The service supplements patients' regular doctors and is offered at no extra cost to eligible members in the US.

2 investors

LCP is a tech-enabled consultancy providing advisory services in pensions, investment, insurance, energy transition, health, and sports. The firm combines human expertise with analytics and in-house technology tools to deliver strategic advice to financial services and corporate clients.

2 investors